Afterload reduction in congestive heart failure

R. R. Miller, N. Awan, Ezra A Amsterdam, D. T. Mason

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In the clinical management of acute and chronic cardiac dysfunction, systemic vasodilators constitute a new approach through their reduction of elevated left ventricular wall tension during systole (ventricular afterload) by decreasing aortic impedance and/or diminishing venous return to the heart. Thus the agents may result in elevation of lowered cardiac output by reducing peripheral vascular resistance and/or in decline of increased ventricular end-diastolic volume (ventricular preload) by lowering venous tone. In addition, these agents cause concomitant reduction in myocardial oxygen requirements which is of special importance in ischemic heart disease.

Original languageEnglish (US)
Pages (from-to)199-204
Number of pages6
JournalAdvances in Cardiology
VolumeVol.22
StatePublished - 1977

Fingerprint

Vascular Resistance
Heart Failure
Systole
Electric Impedance
Vasodilator Agents
Cardiac Output
Stroke Volume
Myocardial Ischemia
Oxygen

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Miller, R. R., Awan, N., Amsterdam, E. A., & Mason, D. T. (1977). Afterload reduction in congestive heart failure. Advances in Cardiology, Vol.22, 199-204.

Afterload reduction in congestive heart failure. / Miller, R. R.; Awan, N.; Amsterdam, Ezra A; Mason, D. T.

In: Advances in Cardiology, Vol. Vol.22, 1977, p. 199-204.

Research output: Contribution to journalArticle

Miller, RR, Awan, N, Amsterdam, EA & Mason, DT 1977, 'Afterload reduction in congestive heart failure', Advances in Cardiology, vol. Vol.22, pp. 199-204.
Miller, R. R. ; Awan, N. ; Amsterdam, Ezra A ; Mason, D. T. / Afterload reduction in congestive heart failure. In: Advances in Cardiology. 1977 ; Vol. Vol.22. pp. 199-204.
@article{4db93bf052254058a79128fb93e93c94,
title = "Afterload reduction in congestive heart failure",
abstract = "In the clinical management of acute and chronic cardiac dysfunction, systemic vasodilators constitute a new approach through their reduction of elevated left ventricular wall tension during systole (ventricular afterload) by decreasing aortic impedance and/or diminishing venous return to the heart. Thus the agents may result in elevation of lowered cardiac output by reducing peripheral vascular resistance and/or in decline of increased ventricular end-diastolic volume (ventricular preload) by lowering venous tone. In addition, these agents cause concomitant reduction in myocardial oxygen requirements which is of special importance in ischemic heart disease.",
author = "Miller, {R. R.} and N. Awan and Amsterdam, {Ezra A} and Mason, {D. T.}",
year = "1977",
language = "English (US)",
volume = "Vol.22",
pages = "199--204",
journal = "Advances in Cardiology",
issn = "0065-2326",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Afterload reduction in congestive heart failure

AU - Miller, R. R.

AU - Awan, N.

AU - Amsterdam, Ezra A

AU - Mason, D. T.

PY - 1977

Y1 - 1977

N2 - In the clinical management of acute and chronic cardiac dysfunction, systemic vasodilators constitute a new approach through their reduction of elevated left ventricular wall tension during systole (ventricular afterload) by decreasing aortic impedance and/or diminishing venous return to the heart. Thus the agents may result in elevation of lowered cardiac output by reducing peripheral vascular resistance and/or in decline of increased ventricular end-diastolic volume (ventricular preload) by lowering venous tone. In addition, these agents cause concomitant reduction in myocardial oxygen requirements which is of special importance in ischemic heart disease.

AB - In the clinical management of acute and chronic cardiac dysfunction, systemic vasodilators constitute a new approach through their reduction of elevated left ventricular wall tension during systole (ventricular afterload) by decreasing aortic impedance and/or diminishing venous return to the heart. Thus the agents may result in elevation of lowered cardiac output by reducing peripheral vascular resistance and/or in decline of increased ventricular end-diastolic volume (ventricular preload) by lowering venous tone. In addition, these agents cause concomitant reduction in myocardial oxygen requirements which is of special importance in ischemic heart disease.

UR - http://www.scopus.com/inward/record.url?scp=0017761846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017761846&partnerID=8YFLogxK

M3 - Article

C2 - 413334

AN - SCOPUS:0017761846

VL - Vol.22

SP - 199

EP - 204

JO - Advances in Cardiology

JF - Advances in Cardiology

SN - 0065-2326

ER -